Golimumab
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Golimumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $231 million on Golimumab across 32,000 claims for 5,263 beneficiaries.
Golimumab is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $7446.21 to $12977.24 per ML — a 74% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$7446.21 – $12977.24
per ML
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Janssen Biotech, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Tumor Necrosis Factor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing GOLIMUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SIMPONI 50 MG/0.5 ML SYRINGE | $12977.2440 per ML | — |
SIMPONI 50 MG/0.5 ML PEN INJEC | $12890.3164 per ML | -0.15% |
SIMPONI 100 MG/ML PEN INJECTOR | $7446.2126 per ML | — |
Frequently Asked Questions
What is Golimumab used to treat?
Golimumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Golimumab?
In 2024, Medicare Part D spent $231 million on Golimumab across 32,000 claims for 5,263 beneficiaries.
How many Golimumab products are on the market?
The Golimumab drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Golimumab?
NADAC reference prices for Golimumab range from $7446.2126 to $12977.2440 per ML — a 74% difference between cheapest and most expensive.
Which manufacturers make Golimumab?
1 manufacturer lists Golimumab in NADAC. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (3).
How has the price of Golimumab changed recently?
Over the past 7 days, 0 Golimumab NDCs rose and 1 fell, with a market-wide average change of -0.1%.